Per Sauerberg

5 Patents

• US122397392025

  Oral Dosing of GLP-1 Compounds

  Novo Nordisk A/S

  0 cites
• US122275282025

  Glucose-sensitive Albumin-binding Derivatives

  Novo Nordisk A/S

  0 cites
• US117673322023

  Glucose-sensitive Albumin-binding Derivatives

  Novo Nordisk A/S

  0 cites
• US115723982023

  GLP-1 Derivatives and Uses Thereof

  Novo Nordisk A/S

  0 cites
• US115411222023

  Glucose Sensitive Insulins and Uses Thereof

  ZIYLO LIMITED

  0 cites